M&A

Orum Therapeutics adds deep clinical and dealmaking expertise to its board, signaling a strategic acceleration of its innovative DAC pipeline for cancer.

Transom Capital Group appoints Luke Dauch, a decade-long J.P. Morgan banker, to bolster its deal origination in a competitive middle-market landscape.

Following a massive stock surge, Forte Biosciences is raising $150M. The funds are crucial for a pivotal year of clinical trials for its autoimmune drug.

In a major strategic move, Premier Research appoints Paul Spreen as CCO, signaling a bold push to capture the rebounding biotech market.

The biopharma firm touts transformative drug data ahead, but with cash for only month-to-month operations, its future hangs by a precarious thread.

The oil producer's new BBB- ratings signal deep financial strength, unlocking lower borrowing costs, enhanced strategic options, and greater shareholder value.

The European FinTech giant plans a new €70M note issue and a tender offer to refinance debt, signaling a major push for financial flexibility and expansion.

Palmer Square Capital BDC reports a drop in 2025 income and asset value but highlights rock-solid credit quality and an optimistic outlook for 2026.

After a massive divestiture, Vistance Networks reports soaring growth, zero debt, and plans a huge special cash distribution to its shareholders.

The biotech firm slashed a major acquisition hurdle in a deal with HealthCare Royalty, signaling strong confidence in its cancer drug ZYNLONTA's future.

With stockholder approval, Abbott's acquisition of Exact Sciences is set to reshape the cancer diagnostics landscape and accelerate early detection.

Tequity Advisors hires ServiceNow pioneer Thomas Moewe, signaling a strategic shift toward deep operational expertise in the booming tech M&A advisory space.

Cenovus Energy reports a record-breaking quarter, with upstream production soaring past 900,000 BOE/d after its landmark acquisition of MEG Energy.

The major CRO acquisition deepens Worldwide's oncology and FSP capabilities, signaling a strategic move in the consolidating clinical research market.

Top policymakers, including Dr. Agustín Carstens and FATF President Luis Urrutia Corral, will convene in Mérida to address critical cross-border tax issues.

A new report shows banks are flush with cash, but this liquidity surge is intensifying competition, squeezing profits, and forcing a high-stakes tech race.

Cohen & Co.-backed SPAC joins the hunt for a merger target, highlighting a renewed investor appetite for blank check companies in a maturing market.

The industrial giant posted strong 2025 results and a cautious 2026 outlook, banking on its execution strategy and key acquisitions in high-growth markets.

Hong Kong's exchange appoints Jalal Almarhoon to spearhead its Riyadh office, signaling a major strategic move to link Asian and Middle Eastern capital.

The vaccine maker posts record 2025 earnings on mpox demand but signals a strategic shift, prioritizing its travel vaccine portfolio over new R&D.